Objective
to report the 2-year clinical outcomes of treatment of left main coronary stenosis with a biodegradable polymer platinum-chromium everolimus stent (BP-PtCR-EES) with 4-month DAPT compared to treatment with a durable polymer cobalt-chromium everolimus-eluting stent (DP-CoCR-EES) with 12-month DAPT
Study
multicentre randomised non-inferiority trial
Population
patients undergoing PCI of left main coronary artery disease
Endpoints
MACE: all-cause death, MI or ischemia-driven target vessel revascularisation at 2 years
Conclusion
the 2-year MACE rate with PCI of LMCA with BP-PtCR-EES stent and 4-month DAPT was non-inferior to treatment with DP-CoCR-EES stent and 12-month DAPT
van Geuns et al. EuroIntervention. 2022; 17:1467-76